These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 16579694)
21. Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation. Teramura Y; Iwata H Transplantation; 2009 Sep; 88(5):624-30. PubMed ID: 19741458 [TBL] [Abstract][Full Text] [Related]
22. Synergism of a natural plant product, oleanolic acid with calcineurin inhibitor in prolonging islet allograft survival. Angaswamy N; Tiriveedhi V; Banan B; Benshoff N; Chapman W; Mohanakumar T Transpl Immunol; 2013 Dec; 29(1-4):64-70. PubMed ID: 24036218 [TBL] [Abstract][Full Text] [Related]
23. Microfluidics-generated pancreatic islet microfibers for enhanced immunoprotection. Jun Y; Kim MJ; Hwang YH; Jeon EA; Kang AR; Lee SH; Lee DY Biomaterials; 2013 Nov; 34(33):8122-30. PubMed ID: 23927952 [TBL] [Abstract][Full Text] [Related]
24. The influence of immune system stimulation on encapsulated islet graft survival. Orłowski TM; Godlewska E; Tarchalska M; Kinasiewicz J; Antosiak M; Sabat M Arch Immunol Ther Exp (Warsz); 2005; 53(2):180-4. PubMed ID: 15928588 [TBL] [Abstract][Full Text] [Related]
25. A Method for Performing Islet Transplantation Using Tissue-Engineered Sheets of Islets and Mesenchymal Stem Cells. Hirabaru M; Kuroki T; Adachi T; Kitasato A; Ono S; Tanaka T; Matsushima H; Sakai Y; Soyama A; Hidaka M; Yamanouchi K; Takatsuki M; Okano T; Eguchi S Tissue Eng Part C Methods; 2015 Dec; 21(12):1205-15. PubMed ID: 26066973 [TBL] [Abstract][Full Text] [Related]
26. Effect of various immunosuppressive monotherapies on survival and histopathology of monkey islet xenografts in rats. Balamurugan AN; Nelson EJ; Ramakrishna B; Gunasekaran S Xenotransplantation; 2007 Jul; 14(4):316-22. PubMed ID: 17669173 [TBL] [Abstract][Full Text] [Related]
27. Beta-cell sparing in transplanted islets by vascular endothelial growth factor. Stagner J; Mokshagundam S; Wyler K; Samols E; Rilo H; Stagner M; Parthasarathy L; Parthasarathy R Transplant Proc; 2004 May; 36(4):1178-80. PubMed ID: 15194408 [TBL] [Abstract][Full Text] [Related]
28. A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets. Contreras JL; Xie D; Mays J; Smyth CA; Eckstein C; Rahemtulla FG; Young CJ; Anthony Thompson J; Bilbao G; Curiel DT; Eckhoff DE Surgery; 2004 Sep; 136(3):537-47. PubMed ID: 15349100 [TBL] [Abstract][Full Text] [Related]
29. Molecularly engineered islet cell clusters for diabetes mellitus treatment. Yook S; Jeong JH; Jung YS; Hong SW; Im BH; Seo JW; Park JB; Lee M; Ahn CH; Lee H; Lee DY; Byun Y Cell Transplant; 2012; 21(8):1775-89. PubMed ID: 22613624 [TBL] [Abstract][Full Text] [Related]
30. Immune reactions of lymphocytes and macrophages against PEG-grafted pancreatic islets. Jang JY; Lee DY; Park SJ; Byun Y Biomaterials; 2004 Aug; 25(17):3663-9. PubMed ID: 15020141 [TBL] [Abstract][Full Text] [Related]
31. Survival and function of transplanted islet cells on an in vivo, vascularized tissue engineering platform in the rat: A pilot study. Brown DL; Meagher PJ; Knight KR; Keramidaris E; Romeo-Meeuw R; Penington AJ; Morrison WA Cell Transplant; 2006; 15(4):319-24. PubMed ID: 16898225 [TBL] [Abstract][Full Text] [Related]
32. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats. Maeda A; Goto M; Zhang J; Bennet W; Groth CG; Korsgren O; Wennberg L Transplantation; 2003 Apr; 75(8):1409-14. PubMed ID: 12717240 [TBL] [Abstract][Full Text] [Related]
33. Immunoisolation of pancreatic islets via thin-layer surface modification. Pathak S; Pham TT; Jeong JH; Byun Y J Control Release; 2019 Jul; 305():176-193. PubMed ID: 31029742 [TBL] [Abstract][Full Text] [Related]
34. Molecular imaging monitoring of poly(ethylene glycol) conjugated islets for evaluation of islet graft rejection. Jeong JH Arch Pharm Res; 2015; 38(5):785-90. PubMed ID: 24862650 [TBL] [Abstract][Full Text] [Related]
35. Immobilization of soluble complement receptor 1 on islets. Luan NM; Teramura Y; Iwata H Biomaterials; 2011 Jul; 32(20):4539-45. PubMed ID: 21459435 [TBL] [Abstract][Full Text] [Related]
37. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. Lopez-Talavera JC; Garcia-Ocaña A; Sipula I; Takane KK; Cozar-Castellano I; Stewart AF Endocrinology; 2004 Feb; 145(2):467-74. PubMed ID: 14551233 [TBL] [Abstract][Full Text] [Related]
38. Transplantation of sertoli-islet cell aggregates formed by microgravity: prolonged survival in diabetic rats. Han X; Qiu L; Zhang Y; Kong Q; Wang H; Wang H; Li H; Duan C; Wang Y; Song Y; Wang C Exp Biol Med (Maywood); 2009 May; 234(5):595-603. PubMed ID: 19244542 [TBL] [Abstract][Full Text] [Related]
39. Surface modification of pancreatic islets using heparin-DOPA conjugate and anti-CD154 mAb for the prolonged survival of intrahepatic transplanted islets in a xenograft model. Jung YS; Jeong JH; Yook S; Im BH; Seo J; Hong SW; Park JB; Yang VC; Lee DY; Byun Y Biomaterials; 2012 Jan; 33(1):295-303. PubMed ID: 21982296 [TBL] [Abstract][Full Text] [Related]
40. HMGB1 modulation in pancreatic islets using a cell-permeable A-box fragment. Hwang YH; Kim MJ; Lee YK; Lee M; Lee DY J Control Release; 2017 Jan; 246():155-163. PubMed ID: 28038946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]